Express Scripts is the only one out of the big three PBMs that hasn't yet made an acquisition to directly support a personalized medicine focus. However, the firm has expressed an interest in applying PGx strategies to rein in healthcare costs, and acquiring Medco would bring it such capabilities.
Medco made a $5 million commitment this week to open a new school of pharmacy at New Jersey-based Fairleigh Dickinson University. The school, which will focus heavily on educating pharmacists about personalized medicine, is slated to open its doors in fall 2012.
The study found that when doctors and their patients were educated about PGx-guided dosing for warfarin and tamoxifen in a pharmacy-initiated personalized medicine program, the testing rate increased 45-fold for warfarin and seven-fold for tamoxifen.
The 13 drugs for which CVS Caremark customers will have the option to sign up for genetic testing includes a range of treatments for cancer, HIV, and other indications, but the anticoagulant warfarin is not on the list.
During cost-conscious times, a genetic testing management company is trying to guide employers and healthcare plans on how to implement genetic testing so it yields savings and improves the health of its members.